Enanta Pharmaceuticals (NASDAQ:ENTA) Posts Earnings Results, Beats Estimates By $0 78 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Enanta Pharmaceuticals (NASDAQ:ENTA) Issues Quarterly Earnings Results, Beats Estimates By $0 78 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Enanta Pharmaceuticals (NASDAQ:ENTA – Get Free Report) announced its quarterly earnings data on Monday. The biotechnology company reported ($1.33) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.11) by $0.78, MarketWatch Earnings reports. The business had revenue of $18.93 million for the quarter, compared to analyst estimates of $17.93 million. Enanta Pharmaceuticals […]
Enanta Pharmaceuticals (NASDAQ:ENTA) Downgraded by StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have been assigned a consensus rating of “Hold” from the eight brokerages that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating on […]